Overview

Predictors of AIS Unfavorable Outcomes

Status:
Completed

Trial end date:
2023-06-29

Target enrollment:

Participant gender:

Summary

The investigators evaluated whether the characteristics of ischemic stroke patients, door-to-needle time, and stroke risk factors were predictive variables for unfavourable outcomes.

Phase:

Phase 4

Details

Lead Sponsor:

Kafrelsheikh University

Treatments:

Tissue Plasminogen Activator